These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25623860)

  • 41. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
    Allard MA; Sebagh M; Ruiz A; Guettier C; Paule B; Vibert E; Cunha AS; Cherqui D; Samuel D; Bismuth H; Castaing D; Adam R
    J Hepatol; 2015 Jul; 63(1):83-92. PubMed ID: 25646884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma.
    Huang J; He X; Lin X; Zhang C; Li J
    Chin Med J (Engl); 2000 May; 113(5):446-8. PubMed ID: 11776102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB; Weissman J; Perkins JD
    Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
    Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
    Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
    AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma.
    Richard HM; Silberzweig JE; Mitty HA; Lou WY; Ahn J; Cooper JM
    Radiology; 2000 Mar; 214(3):775-9. PubMed ID: 10715045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.
    Dharancy S; Boitard J; Decaens T; Sergent G; Boleslawski E; Duvoux C; Vanlemmens C; Meyer C; Gugenheim J; Durand F; Boillot O; Declerck N; Louvet A; Canva V; Romano O; Ernst O; Mathurin P; Pruvot FR
    Liver Transpl; 2007 May; 13(5):665-71. PubMed ID: 17427172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polyvinyl alcohol embolization adjuvant to oily chemoembolization in advanced hepatocellular carcinoma with arterioportal shunts.
    Kim YJ; Lee HG; Park JM; Lim YS; Chung MH; Sung MS; Yoo WJ; Lim HW
    Korean J Radiol; 2007; 8(4):311-9. PubMed ID: 17673842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
    Pinter M; Hucke F; Graziadei I; Vogel W; Maieron A; Königsberg R; Stauber R; Grünberger B; Müller C; Kölblinger C; Peck-Radosavljevic M; Sieghart W
    Radiology; 2012 May; 263(2):590-9. PubMed ID: 22438359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preresection transarterial chemoembolization for hepatocellular carcinoma: an experience with 23 patients.
    Goel M; Gaikwad V; Dharia T; Kulkarni S; Shetty N; Shrikhande SV
    Indian J Gastroenterol; 2014 Sep; 33(5):432-9. PubMed ID: 25037076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
    Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
    J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presurgical transarterial chemoembolization does not increase biliary stricture incidence in orthotopic liver transplant patients.
    Casadaban L; Malespin M; Cheung A; McGuffey RA; Boulay BR; Halline AG; Brown RD; Cotler SJ; Jeon H; Bui JT; Gaba RC
    Transplant Proc; 2014 Jun; 46(5):1413-9. PubMed ID: 24935306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a safety index of transarterial chemoembolization for hepatocellular carcinoma to prevent acute liver damage.
    Hwang JI; Chow WK; Hung SW; Li TC; Cheng YP; Ho YJ; Lin CC
    Anticancer Res; 2005; 25(3c):2551-4. PubMed ID: 16080491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
    Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
    J Surg Oncol; 2010 May; 101(6):476-80. PubMed ID: 20213741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcatheter arterial chemoembolization through collateral arteries for hepatocellular carcinoma after arterial occlusion.
    Shibata T; Kojima N; Tabuchi T; Itoh K; Konishi J
    Radiat Med; 1998; 16(4):251-6. PubMed ID: 9814419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparison of hepatic resection and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria].
    Guo Z; Xiang B; Zhang J; Jiang J; Li L
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1526-9. PubMed ID: 25146737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
    Wong LL; Tanaka K; Lau L; Komura S
    Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety of transarterial chemoembolization as bridging therapy in HCC patients with hyperbilirubinemia on the waiting list for liver transplantation: a centre experience.
    Thorat A; Lee CF; Wu TH; Chan KM; Chou HS; Lee WC
    Hepatogastroenterology; 2013; 60(128):2076-9. PubMed ID: 24719950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.